GlobeNewsWire
20 Jul 2026, 19:46 UTC · 11h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Cosmos Health expects annualized orders for its Sky Premium Life brand in Albania to exceed 54,000 units following an expanded partnership with Pharma Cell. — Directly increases projected sales volume and revenue potential for a specific product line in a growth market.
+0.30Average monthly orders for the Sky Premium Life brand in Albania are currently exceeding 4,500 units. — Provides a concrete baseline of current demand to validate the company's growth projections.
+0.20Which stocks this story touches
The company is expanding its partnership in Albania with projected annualized orders exceeding 54,000 units.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
6h ago
